Harris Henry
Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Bioessays. 2005 Aug;27(8):833-8. doi: 10.1002/bies.20263.
Despite the spectacular contributions to knowledge made by molecular biology during the last half century, cancer research has not delivered an agreed explanation of how malignant tumours originate. The models assiduously investigated in molecular terms largely reflect waves of fashion, and time has revealed their inadequacy: cancer is (1) not caused by the direct action of oncogenes, (2) not fully explained by the impairment of tumour suppressor genes, (3) not set in motion by mutations controlling the cell cycle, (4) not governed by the dependence of malignant tumours on an adequate blood supply and (5) not triggered by a failure of programmed cell death. But there is now strong evidence that cancers may have their origin in mutations that block the execution of critical steps in the process of normal differentiation. Cancer, thus seen, is not initially a disease of cell multiplication, but a disease of differentiation. The evidence for this point of view should now be explored.
尽管分子生物学在过去半个世纪里为知识做出了卓越贡献,但癌症研究尚未就恶性肿瘤的起源给出一个公认的解释。从分子层面上精心研究的模型很大程度上反映了时尚潮流,而时间已经揭示了它们的不足之处:癌症(1)不是由癌基因的直接作用引起的,(2)不能完全由肿瘤抑制基因的损伤来解释,(3)不是由控制细胞周期的突变启动的,(4)不受恶性肿瘤对充足血液供应的依赖所支配,(5)不是由程序性细胞死亡的失败引发的。但现在有强有力的证据表明,癌症可能起源于阻止正常分化过程中关键步骤执行的突变。如此看来,癌症最初不是细胞增殖疾病,而是分化疾病。现在应该探讨支持这一观点的证据。